Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170M
-
Number of holders
-
314
-
Total 13F shares, excl. options
-
171M
-
Shares change
-
+8.83M
-
Total reported value, excl. options
-
$2.85B
-
Value change
-
+$139M
-
Put/Call ratio
-
0.17
-
Number of buys
-
159
-
Number of sells
-
-136
-
Price
-
$16.61
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q1 2025
368 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q1 2025.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 314 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 171M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (42.9M shares), BlackRock, Inc. (21.4M shares), VANGUARD GROUP INC (15.2M shares), RTW INVESTMENTS, LP (8.54M shares), STATE STREET CORP (6.99M shares), MORGAN STANLEY (4.68M shares), Point72 Asset Management, L.P. (4.65M shares), Assenagon Asset Management S.A. (3.66M shares), GEODE CAPITAL MANAGEMENT, LLC (2.95M shares), and FRED ALGER MANAGEMENT, LLC (2.77M shares).
This table shows the top 314 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.